01/02/2026
Asthma and COPD are common obstructive lung diseases that affect a large portion of the population. Although they share similar symptoms, their underlying pathophysiology differs, requiring distinct treatment strategies. Advances in biologic therapies underscore the importance of pulmonologists having a deeper understanding of lung immunobiology. This ATS Ed+ module is designed to address knowledge gaps in immunology, helping pulmonologists use biologics more effectively in clinical practice.
Learn more and earn CME: https://atsedplus.thoracic.org/content/immunology-obstructive-lung-disease-and-emergence-biologic-treatment